Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback